StenoCare Q3 EBITDA turns negative at DKK 244,000; Q3 net sales rise 53% to DKK 2.94 million
Bitget2026/10/29 07:02- StenoCare swung to negative EBITDA of DKK 244,000 in Q3 2026 from positive DKK 59,000 a year earlier.
- Net sales rose 53% year over year to DKK 2.94 million in the quarter.
- Nine-month net sales more than doubled to DKK 9.94 million from a year earlier.
- The 2026 figures include CannGros, while 2025 income statement comparisons cover StenoCare alone.
- German sales remained below expectations due to prescription and reimbursement changes affecting patient access.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.
The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.
Turtle Creek Asset Management Reports Sale of $347,850 in Jeld-Wen Common Shares
GLOBALFOUNDRIES Director Ganesh Moorthy Reports $93,687.50 Share Acquisition
Crypto prices
More
